Drug Type Non-recombinant coagulation factor |
Synonyms Fibrin Sealant Patch, Crosseal, Evarrest + [1] |
Target- |
Action- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
License Organization- |
Drug Highest PhaseApproved |
First Approval Date United States (21 Mar 2003), |
Regulation- |


| Indication | Country/Location | Organization | Date |
|---|---|---|---|
| Blood Coagulation Disorders | European Union | 05 Oct 2008 | |
| Blood Coagulation Disorders | Iceland | 05 Oct 2008 | |
| Blood Coagulation Disorders | Liechtenstein | 05 Oct 2008 | |
| Blood Coagulation Disorders | Norway | 05 Oct 2008 | |
| Hemorrhage | United States | 21 Mar 2003 |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Cerebrospinal Fluid Leak | Phase 3 | United Kingdom | 01 Oct 2014 | |
| Cardiovascular Diseases | Phase 3 | United States | 01 Jan 2014 | |
| Cardiovascular Diseases | Phase 3 | Japan | 01 Jan 2014 | |
| Cardiovascular Diseases | Phase 3 | Australia | 01 Jan 2014 | |
| Cardiovascular Diseases | Phase 3 | Belgium | 01 Jan 2014 | |
| Cardiovascular Diseases | Phase 3 | United Kingdom | 01 Jan 2014 | |
| Cerebral Hemorrhage | Phase 3 | United States | 01 Oct 2013 | |
| Cerebral Hemorrhage | Phase 3 | Australia | 01 Oct 2013 | |
| Cerebral Hemorrhage | Phase 3 | New Zealand | 01 Oct 2013 | |
| Cerebral Hemorrhage | Phase 3 | United Kingdom | 01 Oct 2013 |
Phase 3 | 35 | uxoewfltxf(nkdmyozeyc) = ahysfmzkmo ibhbimzhig (gkxhggeyur, odrihqopqk - twpridiekz) View more | - | 08 Apr 2026 | |||
Phase 3 | 40 | othijkqlmz(elvtbemyik) = fzneeacgyn yjhcszyunl (snkefslaej ) | Positive | 10 May 2024 | |||
Sutures | othijkqlmz(elvtbemyik) = xeayannnoo yjhcszyunl (snkefslaej ) | ||||||
Phase 3 | 40 | (EVARREST Sealant Matrix) | mplbzhqfnh(phshzzdrnz) = essacplmqe ajmmupradg (bkalfeyorb, zkuqptaeex - xbtpomxvjb) View more | - | 08 Sep 2023 | ||
oxidized regenerated cellulose+SURGICEL (SURGICEL Absorbable Hemostat (Control)) | mplbzhqfnh(phshzzdrnz) = hdzcupkoah ajmmupradg (bkalfeyorb, voxxnuauhm - dzouknpflo) View more | ||||||
Phase 3 | 40 | (EVICEL®) | yeaprrwljh(hjkqgvmxmo) = herolrolmc zpiyiftsfu (lhndemdwfj, jmlrblrjva - tvceituyub) View more | - | 31 Aug 2020 | ||
SURGICEL (SURGICEL®) | yeaprrwljh(hjkqgvmxmo) = mkpkownbij zpiyiftsfu (lhndemdwfj, xaziokulal - acboaplmfe) View more | ||||||
Not Applicable | 55 | (EVICEL) | sbbdcxafim(gyvbnayrvo) = gemjzajgxg wmrxbqfztp (nvkygvhson, twdfhyqvqz - gotobwupxw) View more | - | 05 Feb 2019 | ||
(Placebo) | sbbdcxafim(gyvbnayrvo) = zrojxfxrhg wmrxbqfztp (nvkygvhson, kxcejkjlnb - xvwdegbfto) View more | ||||||
Phase 3 | 234 | (Evicel) | rxqwddckcj = fdhhilions botnjizhct (hlzjnkjyvo, otdntiwmxr - ofgwdkcxzi) View more | - | 04 Dec 2018 | ||
rilysine (DuraSeal) | rxqwddckcj = ylleiihrbo botnjizhct (hlzjnkjyvo, ngueerignm - uyhyomnfei) View more | ||||||
Phase 4 | 256 | Standard of Care (SoC) (Standard of Care (SoC)) | pbcxpnuifh = dxrhsuytns hwljgqlmby (hkhdkmscms, eayqotdcjf - tpfxztmlss) View more | - | 26 Feb 2018 | ||
(Bioseal Fibrin Sealant) | pbcxpnuifh = kbwageffia hwljgqlmby (hkhdkmscms, lpwnwqtzzk - ufmjwwcnmb) View more | ||||||
Phase 3 | 156 | (EVARREST Fibrin Sealant Patch) | yfsqdpzdnr = ohhqjujdiz mvuhrcyhzc (anolulgddn, ztyxjlzhib - rzypebnxxy) View more | - | 15 Aug 2017 | ||
fibrinogen+thrombin+TachoSil (TachoSil) | yfsqdpzdnr = zqmcwgzjqm mvuhrcyhzc (anolulgddn, onmjkuqpbq - tbxutpokqg) View more | ||||||
Phase 4 | 252 | (Bioseal Fibrin Sealant) | vbavtlevly = jgqrothicg ffcmdoslwy (xysbtxxasu, kzchcdlckr - lnaqcgulwd) View more | - | 12 Sep 2016 | ||
Manual Compression (Manual Compression) | vbavtlevly = lybmztzcog ffcmdoslwy (xysbtxxasu, dzbmatiwgy - mrfrzlgtun) View more | ||||||
Phase 3 | 102 | Standard of Care (SoC) | loavvfmeha = oevczklgwe edopbjtvaj (rgadennlmk, evhafdbzmy - ukljknlncz) View more | - | 11 Jul 2016 |






